(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

BD 231597 - Sensi-Disc Amikacin, 30 mcg Antimicrobial Susceptibility Testing Discs, 10/BX

BD  # 231597 - Sensi-Disc Amikacin, 30 mcg Antimicrobial Susceptibility Testing Discs, 10/BX
Part Number BD 231597
SKU Number CIA1127832
Sell Unit BOX
Ships Within Special Order
List Price $195.37
Enter a valid quantity
Product Description

BD 231597 - Sensi-Disc Amikacin, 30 mcg Antimicrobial Susceptibility Testing Discs, 10/BX

The BD 231597 - BD Sensi-Disc Amikacin 30 mcg is a high-quality antimicrobial susceptibility testing (AST) disc designed to determine bacterial sensitivity or resistance to the antibiotic amikacin. Each disc contains 30 micrograms of amikacin and is precisely manufactured by Becton Dickinson (BD) to ensure consistent potency and diffusion performance in the standardized Kirby-Bauer disc diffusion method. These discs are essential for clinical microbiology laboratories conducting susceptibility testing on Gram-negative bacteria, particularly members of the Enterobacteriaceae family and Pseudomonas species.

The BD Sensi-Disc line is globally recognized for its precision, stability, and compliance with CLSI (Clinical and Laboratory Standards Institute) performance standards, supporting accurate and reproducible antimicrobial resistance profiling in clinical diagnostics and research environments.

Key Benefits

The BD Sensi-Disc Amikacin 30 mcg provides high reproducibility, stability, and uniform antibiotic diffusion, resulting in reliable inhibition zone measurements. Each disc is impregnated with a carefully controlled amount of amikacin, ensuring consistent antimicrobial activity across all tests. The discs are packaged in moisture-resistant cartridges with built-in desiccants, preserving potency and extending shelf life. The use of BDs stringent manufacturing process guarantees lot-to-lot consistency and compliance with international quality standards, reducing variability and ensuring accuracy in susceptibility testing results.

Compatibility and Applications

The BD 231597 Amikacin Sensi-Disc is designed for use with standard Mueller-Hinton agar plates and is compatible with both manual and automated disc diffusion systems. It is used in laboratories for:

  • Determining the susceptibility of bacterial isolates to amikacin in clinical diagnostics.
  • Antimicrobial resistance surveillance and epidemiological studies.
  • Pharmaceutical and research testing for antibiotic efficacy.
  • Routine clinical testing in hospitals, reference, and public health laboratories.

The 30 mcg amikacin disc is particularly effective for testing Gram-negative organisms such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Enterobacter species.

Usage Guidelines

Use the BD Sensi-Disc Amikacin discs according to CLSI-recommended Kirby-Bauer disc diffusion procedures. Prepare a standardized bacterial suspension equivalent to a 0.5 McFarland standard and inoculate the surface of Mueller-Hinton agar evenly. Using sterile forceps or a disc dispenser, place the amikacin disc on the agar surface, ensuring firm contact. Incubate the plates at 35 2C for 1618 hours under aerobic conditions. After incubation, measure the diameter of the inhibition zone in millimeters and interpret results based on CLSI M100 performance standards. Always store unused discs at 28C in the original cartridge with desiccant to maintain potency.

Certifications, Safety Standards, and Regulatory Approvals

The BD Sensi-Disc Amikacin discs are FDA-cleared and CE-marked for in vitro diagnostic (IVD) use. They are manufactured in compliance with ISO 13485:2016 and ISO 9001 quality management systems. Each batch is tested for antibiotic content uniformity, diffusion performance, and sterility according to CLSI and WHO standards. BDs facilities follow Good Manufacturing Practices (GMP) and quality control processes to ensure consistent, validated product performance across clinical and research laboratories worldwide.

Comparison with Competitor Products

Compared with other antibiotic susceptibility discs, the BD Sensi-Disc Amikacin 30 mcg provides unmatched precision and stability. Many competitor brands show variability in antibiotic loading or inconsistent diffusion rates, leading to unreliable results. BDs proprietary manufacturing and quality assurance ensure uniform antibiotic concentration and consistent zone diameters. The advanced packaging technology, including desiccant-protected cartridges, maintains long-term disc potency and prevents moisture degradationoffering superior reliability in routine and reference laboratory use.

Typical User Profile and Application Scenarios

This product is used by clinical microbiologists, laboratory technologists, and research professionals conducting antimicrobial susceptibility testing. Typical users include hospital diagnostic labs, pharmaceutical quality control departments, academic research institutions, and public health reference laboratories. The BD Sensi-Disc Amikacin discs are especially suited for routine clinical testing, antibiotic resistance surveillance, and comparative antibiotic efficacy studies in regulated laboratory environments.

Best Practices for Use and Maintenance

Store discs at 28C in their sealed cartridges to protect them from moisture and temperature fluctuations. Allow discs to reach room temperature before opening to prevent condensation. Handle discs with sterile forceps or an automatic dispenser to avoid contamination. Close the cartridge immediately after use and return it to cold storage. Perform routine quality control with recommended ATCC reference strains such as Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 to verify potency and consistency. Dispose of used discs and plates according to institutional biohazard waste guidelines.

Regulatory and Safety Information

The BD 231597 - BD Sensi-Disc Amikacin 30 mcg discs comply with all applicable FDA, CE, and ISO standards for in vitro diagnostic reagents. They are non-toxic, non-hazardous, and contain only pharmaceutical-grade antibiotic material embedded in inert filter paper. Safety Data Sheets (SDS) are available from BD upon request. The product is intended for professional use only and should be handled following laboratory biosafety protocols for infectious materials. Avoid ingestion or contact with the eyes and wash hands after handling discs or bacterial cultures.

How to Order

To order the BD 231597 - BD Sensi-Disc Amikacin (30 mcg Antimicrobial Susceptibility Discs), add the item to your cart and complete checkout through CIA Medical. We offer competitive pricing, fast delivery, and dependable customer service for hospitals, clinical laboratories, and research institutions. For bulk orders, performance documentation, or product availability, c

Related Products